Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000245209 | SCV000307466 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000325201 | SCV000468242 | uncertain significance | Primary ciliary dyskinesia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000325201 | SCV000624106 | benign | Primary ciliary dyskinesia | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000726713 | SCV000702337 | uncertain significance | not provided | 2016-10-22 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000726713 | SCV001155052 | uncertain significance | not provided | 2017-01-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000325201 | SCV002690329 | likely benign | Primary ciliary dyskinesia | 2015-06-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Laboratory of Diagnostic Genome Analysis, |
RCV000726713 | SCV001799302 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000726713 | SCV001971221 | likely benign | not provided | no assertion criteria provided | clinical testing |